Article
Identification of three novel DNMT3A mutations with compromising methylation capacity in human acute myeloid leukaemia.
Molecular biology reports - 1 Dec 2022
Ali Ayad M, Salih Gaza F
Abstract excerpt
BACKGROUND: Acute myeloid leukaemia (AML) is a complex and heterogeneous hematopoietic stem and progenitor cell malignancy characterised by the accumulation of immature blast cells in the bone marrow, blood, and other organs linked to environmental, genetic, and epigenetic factors. Somatic mutations in the gene DNA (cytosine-5)-methyltransferase 3A (DNMT3A; NM_022552.4) are common in AML patients. METHODS: In...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
